Level Four Advisory Services’s Biogen BIIB Stock Holding History

Level Four Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,154	Closed	-$2.21M	–	788
2025 Q1	$2.21M	Buy	16,154 +8,685	+116%	+$1.24M	0.09%	237
2024 Q4	$1.14M	Sell	7,469 -2,828	-27%	-$477K	0.05%	313
2024 Q3	$1.79M	Sell	10,297 -125	-1%	-$26.2K	0.08%	250
2024 Q2	$2.42M	Buy	10,422 +3,210	+45%	+$698K	0.11%	210
2024 Q1	$1.87M	Buy	7,212 +13	+0.2%	+$3.04K	0.1%	212
2023 Q4	$1.86M	Sell	7,199 -158	-2%	-$38.8K	0.1%	209
2023 Q3	$1.89M	Buy	7,357 +271	+4%	+$72.5K	0.12%	193
2023 Q2	$2.02M	Buy	7,086 +35	+0.5%	+$10.4K	0.12%	187
2023 Q1	$1.96M	Sell	7,051 -34	-0.5%	-$9.41K	0.13%	181
2022 Q4	$1.96M	Sell	7,085 -1,126	-14%	-$318K	0.15%	171
2022 Q3	$2.19M	Sell	8,211 -8,427	-51%	-$1.79M	0.21%	122
2022 Q2	$3.39M	Buy	16,638 +719	+5%	+$147K	0.32%	88
2022 Q1	$3.35M	Buy	15,919 +3,907	+33%	+$850K	0.26%	103
2021 Q4	$2.88M	Buy	12,012 +2,377	+25%	+$611K	0.22%	120
2021 Q3	$2.73M	Buy	9,635 +10	+0.1%	+$3.28K	0.28%	101
2021 Q2	$3.33M	Buy	9,625 +614	+7%	+$186K	0.23%	115
2021 Q1	$2.52M	Buy	9,011 +3,873	+75%	+$1.04M	0.2%	132
2020 Q4	$1.26M	Sell	5,138 -1,379	-21%	-$356K	0.1%	205
2020 Q3	$1.85M	Buy	6,517 +791	+14%	+$221K	0.14%	156
2020 Q2	$1.54M	Sell	5,726 -590	-9%	-$177K	0.12%	183
2020 Q1	$1.99M	Buy	6,316 +507	+9%	+$154K	0.24%	109
2019 Q4	$8.67M	Buy	5,809 +925	+19%	+$257K	0.34%	89
2019 Q3	$1.14M	Buy	4,884 +454	+10%	+$106K	0.12%	185
2019 Q2	$1.04M	Buy	4,430 +138	+3%	+$31.9K	0.1%	191
2019 Q1	$1.01M	Buy	4,292 +278	+7%	+$87.5K	0.11%	193
2018 Q4	$1.21M	Buy	4,014 +903	+29%	+$288K	0.15%	150
2018 Q3	$1.1M	Buy	+3,111	New	+$1.07M	0.12%	183

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Level Four Advisory Services's BIIB Position: Q2 2025 in Review

Level Four Advisory Services sold out of Biogen (BIIB) in Q2 2025, closing a stake of 16,154 shares — an estimated $2.21M sold.

Level Four Advisory Services first reported a position in BIIB in Q3 2018 and held it in 27 quarters. The position peaked at $8.67M in Q4 2019. 867 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

Level Four Advisory Services reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
Level Four Advisory Services sold 16,154 Biogen shares in Q2 2025, an estimated $2.21M.
Level Four Advisory Services first reported a position in Biogen in Q3 2018 and held it in 27 quarters.
Level Four Advisory Services's Biogen position peaked at $8.67M in Q4 2019.
867 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Level Four Advisory Services's 13F filing for Q2 2025, filed 13 Aug 2025.